Английская Википедия:ADB-5'Br-BUTINACA
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Infobox drug
ADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug,[1] first detected in Philadelphia in the US in May 2022,[2] and subsequently found in South Korea,[3] Portugal and Sweden.[4] It is specifically listed as an illegal drug in Italy,[5] South Korea[6] and several states in the US,[7][8] and controlled under analogue legislation in various other jurisdictions.
See also
References
Шаблон:Cannabinoids Шаблон:Cannabinoidergics